Literature DB >> 208153

Retrograde amnesia produced by several treatments: evidence for a common neurobiological mechanism.

P E Gold, D B Sternberg.   

Abstract

This experiment examined the effects on memory of various amnestic treatments in animals earlier treated with the alpha-adrenergic antagonist phenoxybenzamine (PBZ). Thirty minutes before being trained in a one-trial inhibitory (passive) avoidance task, animals received an injection of PBZ or saline. Immediately after training, each animal received one of the following amnestic treatments: stimulation of the frontal cortex or amygdala, pentylenetetrazol, diethyldithiocarbamate, or cycloheximide. In control animals, each treatment produced retrograde amnesia. However, PBZ-treated animals did not develop amnesia. These findings suggest that there may be a common neurobiological mechanism underlying the amnesias produced by many treatments.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 208153     DOI: 10.1126/science.208153

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  11 in total

1.  Hippocampal c-Jun-N-terminal kinases serve as negative regulators of associative learning.

Authors:  Tessi Sherrin; Thomas Blank; Cathrin Hippel; Martin Rayner; Roger J Davis; Cedomir Todorovic
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

2.  Evidence for a possible interaction between noradrenergic and serotonergic neurotransmission in the retrieval of a previously learned aversive habit in mice.

Authors:  H J Normile; H J Altman
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 3.  Protein synthesis inhibition and memory: formation vs amnesia.

Authors:  Paul E Gold
Journal:  Neurobiol Learn Mem       Date:  2007-12-03       Impact factor: 2.877

Review 4.  Protein synthesis inhibitors, gene superinduction and memory: too little or too much protein?

Authors:  Jelena Radulovic; Natalie C Tronson
Journal:  Neurobiol Learn Mem       Date:  2007-09-29       Impact factor: 2.877

5.  Lidocaine attenuates anisomycin-induced amnesia and release of norepinephrine in the amygdala.

Authors:  Renee N Sadowski; Clint E Canal; Paul E Gold
Journal:  Neurobiol Learn Mem       Date:  2011-03-29       Impact factor: 2.877

6.  Memory facilitation by naloxone is due to release of dopaminergic and beta-adrenergic systems from tonic inhibition.

Authors:  I Izquierdo; M Graudenz
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

7.  Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents.

Authors:  R Cumin; E F Bandle; E Gamzu; W E Haefely
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  Amnesia produced by altered release of neurotransmitters after intraamygdala injections of a protein synthesis inhibitor.

Authors:  Clinton E Canal; Qing Chang; Paul E Gold
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-18       Impact factor: 11.205

9.  In vivo turnover of tau and APP metabolites in the brains of wild-type and Tg2576 mice: greater stability of sAPP in the beta-amyloid depositing mice.

Authors:  Jose Morales-Corraliza; Matthew J Mazzella; Jason D Berger; Nicole S Diaz; Jennifer H K Choi; Efrat Levy; Yasuji Matsuoka; Emmanuel Planel; Paul M Mathews
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

10.  Age-dependent dysregulation of brain amyloid precursor protein in the Ts65Dn Down syndrome mouse model.

Authors:  Jennifer H K Choi; Jason D Berger; Matthew J Mazzella; Jose Morales-Corraliza; Anne M Cataldo; Ralph A Nixon; Stephen D Ginsberg; Efrat Levy; Paul M Mathews
Journal:  J Neurochem       Date:  2009-07-10       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.